UB Paderborn / Katalog / Suche / in CDI

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Diabetologia, 2005-09, Vol.48 (9), p.1716-1725

2005

Link zum Volltext

Verfügbarkeit prüfen

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

The Lancet (British edition), 2009-06, Vol.373 (9681), p.2125-2135

2009

Link zum Volltext

Verfügbarkeit prüfen

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Diabetic medicine, 2009-03, Vol.26 (3), p.268-278

2009

Link zum Volltext

Verfügbarkeit prüfen

National Prevalence of Obesity: Prevalence of obesity in Poland

Obesity reviews, 2005-05, Vol.6 (2), p.113-114

2005

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of obesity in Poland

Obesity reviews, 2005-05, Vol.6 (2), p.113-114

2005

Link zum Volltext

Verfügbarkeit prüfen

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials

Diabetologia, 2011-06, Vol.54 (6), p.1298-1303

2011

Link zum Volltext

Verfügbarkeit prüfen

Health status of the children of diabetic mothers

Journal of pediatric endocrinology & metabolism : JPEM, 2001, Vol.14 Suppl 1, p.691

2001

Link zum Volltext

Verfügbarkeit prüfen

Tesaglitazar (GALIDA(TM)) Improves Postprandial Lipid Handling and Glucose Tolerance in an Insulin-Resistant, Non-Diabetic Population

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A152

2005

Link zum Volltext

Verfügbarkeit prüfen

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor [alpha]/[gamma] agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Diabetologia, 2005-09, Vol.48 (9), p.1716

2005

Link zum Volltext

Verfügbarkeit prüfen

Glucose tolerance and insulin secretion during treatment of hyperthyroidism

Endokrynologia polska, 1980-05, Vol.31 (3), p.241

Lopatyński, J

1980

Link zum Volltext

Verfügbarkeit prüfen

Studies of the chemical composition of the aortic wall. V. Effect of Atromid S on some fractions of collagen in the aortic wall of rats fed an atherogenic diet

Polish medical science and history bulletin, 1967-01, Vol.10 (1), p.24

1967

Link zum Volltext

Verfügbarkeit prüfen

High density lipoprotein cholesterol (HDL-Ch) during treatment of hyperthyroidism

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1980-09, Vol.35 (38), p.1449

Lopatyński, J

1980

Link zum Volltext

Verfügbarkeit prüfen

Modern views on the production and secretion of insulin

Wiadomości lekarskie (1960), 1976-08, Vol.29 (16), p.1435

1976

Link zum Volltext

Verfügbarkeit prüfen

The inquiry into the purposes of carelessness in out-patient treatment of arterial hypertension (author's transl)

Przeglad lekarski, 1977, Vol.34 (3), p.345

1977

Link zum Volltext

Verfügbarkeit prüfen

Alterations in serum HDL and LDL cholesterol during antithyroid treatment

Endokrynologia polska, 1981-09, Vol.32 (5), p.415

1981

Link zum Volltext

Verfügbarkeit prüfen

ON THE EFFECT OF A BRIEF ADMINISTRATION OF THE PREPARATION LINODOXINE ON THE BEHAVIOR OF SOME INDICED OF LIPID METABOLISM IN THE BLOOD SERUM

Polskie archiwum medycyny wewne̦trznej, 1963, Vol.33, p.483

1963

Link zum Volltext

Verfügbarkeit prüfen

GENERALIZED THROMBOSIS IN ARTERIOSCLEROSIS

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1964-09, Vol.19, p.1376

1964

Link zum Volltext

Verfügbarkeit prüfen

Studies on the lipid metabolism indicators, glucose tolerance and insulin and glucagon secretion during conservative treatment of thyrotoxicosis. Summary of the thesis

Endokrynologia polska, 1981-05, Vol.32 (3), p.285

Lopatyński, J

1981

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of efficacy, safety and tolerance of glimepiride (Amaryl) in patients with type 2 diabetes

Przeglad lekarski, 2000, Vol.57 Suppl 4, p.23

2000

Link zum Volltext

Verfügbarkeit prüfen

Antiorgan antibodies in rabbits fed atherogenic diet

Archivum Immunologiae et Therapiae Experimentalis, 1972, Vol.20 (4), p.485-489

1972

Link zum Volltext

Verfügbarkeit prüfen

The effect of atherogenic diet and experimental alloxan-induced diabetes on serum levels of proteins, glucose, and lipids in rabbits

Acta physiologica Polonica, 1974-11, Vol.25 (6), p.547

1974

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland)

Polskie archiwum medycyny wewne̦trznej, 2001-09, Vol.106 (3), p.781

2001

Link zum Volltext

Verfügbarkeit prüfen

The effect of experimental hypertension and atherogenic diet on the content of cholesterol in the aorta wall and on the level of lipids in the serum

Annales Universitatis Mariae Curie-Skłodowska. Sectio D, Medicina, 1968, Vol.23, p.55

Lopatyński, J

1968

Link zum Volltext

Verfügbarkeit prüfen

Studies on the chemical composition of vascular walls. IX. Effect of experimentally induced arterial hypertension and atherogenic diet on certain protein fractions of the aortic wall

Polskie archiwum medycyny wewne̦trznej, 1968, Vol.40 (4), p.431

Lopatyński, J

1968

Link zum Volltext

Verfügbarkeit prüfen

Diabetes mellitus and thyroid diseases

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1980-04, Vol.35 (16), p.591

Lopatyński, J

1980

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

National Prevalence of Obesity: Prevalence of obesity in Poland

Prevalence of obesity in Poland

Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials

Health status of the children of diabetic mothers

Tesaglitazar (GALIDA(TM)) Improves Postprandial Lipid Handling and Glucose Tolerance in an Insulin-Resistant, Non-Diabetic Population

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor [alpha]/[gamma] agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Glucose tolerance and insulin secretion during treatment of hyperthyroidism

Studies of the chemical composition of the aortic wall. V. Effect of Atromid S on some fractions of collagen in the aortic wall of rats fed an atherogenic diet

High density lipoprotein cholesterol (HDL-Ch) during treatment of hyperthyroidism

Modern views on the production and secretion of insulin

The inquiry into the purposes of carelessness in out-patient treatment of arterial hypertension (author's transl)

Alterations in serum HDL and LDL cholesterol during antithyroid treatment

ON THE EFFECT OF A BRIEF ADMINISTRATION OF THE PREPARATION LINODOXINE ON THE BEHAVIOR OF SOME INDICED OF LIPID METABOLISM IN THE BLOOD SERUM

GENERALIZED THROMBOSIS IN ARTERIOSCLEROSIS

Studies on the lipid metabolism indicators, glucose tolerance and insulin and glucagon secretion during conservative treatment of thyrotoxicosis. Summary of the thesis

Evaluation of efficacy, safety and tolerance of glimepiride (Amaryl) in patients with type 2 diabetes

Antiorgan antibodies in rabbits fed atherogenic diet

The effect of atherogenic diet and experimental alloxan-induced diabetes on serum levels of proteins, glucose, and lipids in rabbits

The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland)

The effect of experimental hypertension and atherogenic diet on the content of cholesterol in the aorta wall and on the level of lipids in the serum

Studies on the chemical composition of vascular walls. IX. Effect of experimentally induced arterial hypertension and atherogenic diet on certain protein fractions of the aortic wall

Diabetes mellitus and thyroid diseases

Suchergebnisse filtern